ACC: Pre-pPCI Metoprolol Doesn't Reduce Infarct Size in STEMI

Share this content:
ACC: Pre-pPCI Metoprolol Doesn't Reduce Infarct Size in STEMI
ACC: Pre-pPCI Metoprolol Doesn't Reduce Infarct Size in STEMI

TUESDAY, April 5, 2016 (HealthDay News) -- Early intravenous metoprolol before primary percutaneous coronary intervention (pPCI) does not reduce infarct size in a population with ST-segment elevation myocardial infarction (STEMI), according to a study published online April 3 in the Journal of the American College of Cardiology. The research is being published to coincide with the annual meeting of the American College of Cardiology, held from April 2 to 4 in Chicago.

Vincent Roolvink, M.D., from Isala Hospital in Zwolle, Netherlands, and colleagues randomized 683 patients with STEMI presenting <12 hours from symptom onset to intravenous metoprolol (336 patients) or matched placebo (346 patients) before pPCI. Overall, 54.8 percent of the patients underwent magnetic resonance imaging (MRI).

The researchers found that the infarct size did not differ between the metoprolol and placebo groups (P = 0.616). There was no between-group difference noted in the peak and area under the creatine kinase curve. The left ventricular ejection fraction, assessed by MRI, was similar between the groups (P = 0.68). Malignant arrhythmias occurred in 3.6 and 6.9 percent of the metoprolol and placebo groups, respectively (P = 0.050). There was no between-group difference noted in the incidence of adverse events.

"Early intravenous metoprolol before pPCI, was not associated with a reduction in infarct size," the authors write. "Metoprolol reduced the incidence of malignant arrhythmias in the acute phase and was not associated with an increase in adverse events."

The Early-Beta-blocker Administration before primary PCI in patients with ST-elevation Myocardial Infarction (Early-BAMI) trial was partially funded by Medtronic. The QMass software was partially supported by a scientific collaboration between CNIC and Medis.

Full Text (subscription or payment may be required)
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »